Human pluripotent stem cells (hPSCs) provide a scalable, genetic platform for cancer immunotherapy. By engineering iPSCs to create "off-the-shelf" CAR-NK, CAR-T, and CAR-macrophage cells, researchers can enhance anti-tumor activity while reducing immune rejection and toxicity.
References:
* Human pluripotent stem cell-derived innate and adaptive immune cells for cancer immunotherapyShah, Zahir et ...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动
References:
* Human pluripotent stem cell-derived innate and adaptive immune cells for cancer immunotherapyShah, Zahir et ...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动
Fler avsnitt av Paper Talk
Visa alla avsnitt av Paper TalkPaper Talk med 淼淼Elva finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
